Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jacob Gottlieb, Visium Asset Management Boost Stake In Brookdale Senior Living, Inc. (BKD)

Jacob Gottlieb and his fund, Visium Asset Management, have upped their interest in Brookdale Senior Living, Inc. (NYSE:BKD) having increased their stake, according to a recent filing with the Securities and Exchange Commission. Visium has added 2.29 million shares to its previous stake, taking it to 6.31 million shares which account for 5.1% of the total number of shares outstanding.

Brookdale Senior Living, Inc. (NYSE:BKD)

James Dinan is also optimistic about the prospects of Brookdale Senior Living, Inc. (NYSE:BKD) and has increased his fund’s holding by 25% during the fourth quarter of 2013. In its latest 13F filing, York Capital Management has reported ownership of 5.1 million shares valued at $138 million. Among the hedge funds we track that are invested in this stock, the biggest position is held by Fortress Investment Group. Its manager, Michael Novogratz, has built a position comprising 17.5 million shares reportedly worth $478 million.

Brookdale Senior Living, Inc. (NYSE:BKD) operates senior living communities in the United States. The company has a market cap of $3.93 billion and does not pay a dividend. So far this year, the stock has advanced approximately 17% to a current price of $31.62 per share. Brookdale posted revenues of $734 million and earnings per share of $0.07 for the 2013 fourth quarter. The company is expected to register revenues of $746 million and earnings of $0.06 per share for the first quarter of 2014. The stock is mainly recommended as a Buy and a Strong Buy.

In a recent move, Gottlieb has initiated a new position through the acquisition of 1.6 million shares of AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). This gives Visium Asset Management ownership of 7.2% of the company’s common stock. Another two pharmaceutical stocks Gottlieb has recently added to his portfolio are NephroGenex Inc (NASDAQ:NRX) and Ignyta Inc (NASDAQ:RXDX). Visium Asset Management has reported ownership of 476,491 NephroGenex shares, or 5.4% of the common stock, and 833,300 shares of Ignyta Inc, which account for 6.2% of the total number of shares outstanding.

Disclosure: none.

Recommended reading:

Visium Asset Management Ups Stake in Skyrocketing Intercept Pharmaceuticals Inc (ICPT)

Jacob Gottlieb, Visium Asset Management Significantly Increase Zogenix Inc. (ZGNX) Holding

Jacob Gottlieb, Visium Asset Management Boost Exposure to QLT Inc.

Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!